Marketing-authorisation holder · United States

Breckenridge

United States9 medicines1 country

9 medicines in 1 country, as authorisation holder.

Medicines

Every medicine in the registers under its name, current ones first.

9 medicines

Medicine	Substance	Country	Status	Authorised
CABAZITAXEL45mg/4.5ml (10mg/ml) \| 60mg/1.5ml (40mg/ml) \| 60mg/3ml (20mg/ml) \| 60mg/6ml (10mg/ml) · Solution	Cabazitaxel	United States	Marketed	2021
DEHYDRATED ALCOHOL99% (5ml) · Solution	Dehydrated alcohol	United States	Marketed	2025
EVEROLIMUS0.25mg \| 0.5mg \| 0.75mg \| 10mg \| 1mg \| 2.5mg \| 5mg \| 7.5mg · Tablet	Everolimus	United States	Marketed	2018
LAMIVUDINE100mg \| 150mg \| 300mg · Tablet	Lamivudine	United States	Marketed	2005
METHADONE HYDROCHLORIDE10mg/ml · Injectable	Methadone	United States	Marketed	1947
METHSCOPOLAMINE BROMIDE2.5mg \| 5mg · Tablet	Methscopolamine	United States	Marketed	1976
METHYLERGONOVINE MALEATE0.2mg/ml · Injectable	Methylergonovine	United States	Marketed	2008
RIVASTIGMINE13.3mg/24hr \| 4.6mg/24hr \| 9.5mg/24hr · Film, extended release	Rivastigmine	United States	Marketed	2015
TERIFLUNOMIDE14mg \| 7mg · Tablet	Teriflunomide	United States	Marketed	2018

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Marketing-authorisation holder · United States

United States9 medicines1 country

9 medicines in 1 country, as authorisation holder.

Every medicine in the registers under its name, current ones first.

9 medicines

Medicine	Substance	Country	Status	Authorised
CABAZITAXEL45mg/4.5ml (10mg/ml) \| 60mg/1.5ml (40mg/ml) \| 60mg/3ml (20mg/ml) \| 60mg/6ml (10mg/ml) · Solution	Cabazitaxel	United States	Marketed	2021
DEHYDRATED ALCOHOL99% (5ml) · Solution	Dehydrated alcohol	United States	Marketed	2025
EVEROLIMUS0.25mg \| 0.5mg \| 0.75mg \| 10mg \| 1mg \| 2.5mg \| 5mg \| 7.5mg · Tablet	Everolimus	United States	Marketed	2018
LAMIVUDINE100mg \| 150mg \| 300mg · Tablet	Lamivudine	United States	Marketed	2005
METHADONE HYDROCHLORIDE10mg/ml · Injectable	Methadone	United States	Marketed	1947
METHSCOPOLAMINE BROMIDE2.5mg \| 5mg · Tablet	Methscopolamine	United States	Marketed	1976
METHYLERGONOVINE MALEATE0.2mg/ml · Injectable	Methylergonovine	United States	Marketed	2008
RIVASTIGMINE13.3mg/24hr \| 4.6mg/24hr \| 9.5mg/24hr · Film, extended release	Rivastigmine	United States	Marketed	2015
TERIFLUNOMIDE14mg \| 7mg · Tablet	Teriflunomide	United States	Marketed	2018

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	9	9	0	Companies All medicines

The active substances in most of its medicines.

How the registers spell it, normalised: legal forms, accents and capitals removed.

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Report an error or request removalCorrections from the company itself are welcome.

Ranked by their number of medicines.